HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radiofrequency ablation of malignant hepatic neoplasms.

AbstractOBJECTIVE:
To assess the safety and efficacy of radiofrequency ablation (RFA) in the treatment of malignant neoplasms of the liver.
METHODS:
Sixty-seven patients received RFA for primary or secondary hepatic malignancies. Patients were followed prospectively with computed tomography (CT) scanning to assess for therapeutic response, disease progression and complications.
RESULTS:
Eighty-eight lesions were treated, including 57 hepatocellular carcinomas, 28 metastases, 2 cholangiocarcinomas and 1 hepatic plasmacytoma. Mean tumour size was 2.7 cm (range 0.5-6.9 cm). A total of 101 ablations were performed (66 percutaneously, 35 intraoperatively). Over a mean follow-up period of 142 days, results were available for 85 lesions. Local tumour control was achieved for 61 (72%) lesions, but new distant lesions developed in 6 of these cases. Residual disease was present in 20 (23%) lesions, and 4 (5%) lesions developed local recurrence. There were 10 complications, including 1 death in a patient who developed a liver abscess and subsequently died from hepatic failure.
CONCLUSIONS:
RFA is safe and effective in the treatment of hepatic malignancies. Local tumour control can be achieved in most cases; however, careful surveillance is important for detecting recurrent disease, as well as new lesions distant from the treated site.
AuthorsRaymond P Chan, Murray Asch, John Kachura, Chia-Sing Ho, Paul Greig, Bernard Langer, Morris Sherman, Florence Wong, Ronald Feld, Steven Gallinger
JournalCanadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes (Can Assoc Radiol J) Vol. 53 Issue 5 Pg. 272-8 (Dec 2002) ISSN: 0846-5371 [Print] United States
PMID12500378 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Contrast Media
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Hepatocellular (diagnostic imaging, secondary, surgery)
  • Catheter Ablation (adverse effects, methods)
  • Contrast Media
  • Female
  • Humans
  • Liver Neoplasms (diagnostic imaging, secondary, surgery)
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Neoplasm, Residual
  • Prospective Studies
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: